These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

53 related items for PubMed ID: 7565583

  • 21. Chimeric tumor suppressor 1, a p53-derived chimeric tumor suppressor gene, kills p53 mutant and p53 wild-type glioma cells in synergy with irradiation and CD95 ligand.
    Naumann U, Kügler S, Wolburg H, Wick W, Rascher G, Schulz JB, Conseiller E, Bähr M, Weller M.
    Cancer Res; 2001 Aug 01; 61(15):5833-42. PubMed ID: 11479223
    [Abstract] [Full Text] [Related]

  • 22. [Tumor suppressor gene p53: mechanisms of action in cell proliferation and death].
    Mendoza-Rodríguez CA, Cerbón MA.
    Rev Invest Clin; 2001 Aug 01; 53(3):266-73. PubMed ID: 11496714
    [Abstract] [Full Text] [Related]

  • 23. Glycerol enhances CDDP-induced growth inhibition of thyroid anaplastic carcinoma tumor carrying mutated p53 gene.
    Yuki K, Takahashi A, Ota I, Ohnishi K, Yasumoto J, Kanata H, Yane K, Hosoi H, Ohnishi T.
    Oncol Rep; 2004 Apr 01; 11(4):821-4. PubMed ID: 15010879
    [Abstract] [Full Text] [Related]

  • 24. Apoptosis induced by adenovirus-mediated p53 gene transfer in human glioma correlates with site-specific phosphorylation.
    Shono T, Tofilon PJ, Schaefer TS, Parikh D, Liu TJ, Lang FF.
    Cancer Res; 2002 Feb 15; 62(4):1069-76. PubMed ID: 11861384
    [Abstract] [Full Text] [Related]

  • 25. The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer.
    Smith ND, Rubenstein JN, Eggener SE, Kozlowski JM.
    J Urol; 2003 Apr 15; 169(4):1219-28. PubMed ID: 12629332
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Is conversion of solid into more anoxic ascites tumors associated with p53 inactivation?
    Magnusson KP, Satalino R, Qian W, Klein G, Wiman KG.
    Oncogene; 1998 Nov 05; 17(18):2333-7. PubMed ID: 9811464
    [Abstract] [Full Text] [Related]

  • 28. [Apoptosis of hepatocarcinoma cell line HLE induced by the combination of wild type P53 gene and 1,2:5,6-dianhydro-3,4-diacetylgalactitol].
    Lai XJ, Cao LZ, Zhou Y, Lan XW, Liao ZH, Zhou SF.
    Ai Zheng; 2004 Oct 05; 23(10):1139-43. PubMed ID: 15473923
    [Abstract] [Full Text] [Related]

  • 29. The concepts in poorly differentiated carcinoma of the thyroid: a review article.
    Nambiar A, Pv S, Susheelan V, Kuriakose MA.
    J Surg Oncol; 2011 Jun 05; 103(8):818-21. PubMed ID: 21283991
    [Abstract] [Full Text] [Related]

  • 30. Dominant-negative mutation of p53 tumor suppressor gene in endometrial carcinoma.
    Sakuragi N, Hirai A, Tada M, Yamada H, Yamamoto R, Fujimoto S, Moriuchi T.
    Gynecol Oncol; 2001 Dec 05; 83(3):485-90. PubMed ID: 11733960
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Molecular genetic alterations of FHIT and p53 genes in benign and malignant thyroid gland lesions.
    Pavelić K, Dedivitis RA, Kapitanović S, Cacev T, Guirado CR, Danić D, Radosević S, Brkić K, Pegan B, Krizanac S, Kusić Z, Spaventi S, Bura M.
    Mutat Res; 2006 Jul 25; 599(1-2):45-57. PubMed ID: 16698048
    [Abstract] [Full Text] [Related]

  • 35. Expression of bcl-2, c-erbB-2, p53, and p21 (waf1-cip1) protein in thyroid carcinomas.
    Soda G, Antonaci A, Bosco D, Nardoni S, Melis M.
    J Exp Clin Cancer Res; 1999 Sep 25; 18(3):363-7. PubMed ID: 10606183
    [Abstract] [Full Text] [Related]

  • 36. Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland.
    Donghi R, Longoni A, Pilotti S, Michieli P, Della Porta G, Pierotti MA.
    J Clin Invest; 1993 Apr 25; 91(4):1753-60. PubMed ID: 8473515
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Expression of bcl-2, c-erbB-2, p53, and p21 (waf1-cip1) protein in thyroid carcinomas.
    Soda G, Antonaci A, Bosco D, Nardoni S, Melis M.
    J Exp Clin Cancer Res; 1999 Sep 25; 18(3):363-7. PubMed ID: 10606183
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 3.